Stay updated on CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.

Latest updates to the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0 in the footer, indicating a software update. No study content or navigation elements were altered.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a new revision tag v3.6.6, replacing the previous v3.6.5, indicating a small metadata update to the page.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded 2015 ( U.S. NIH Grant/Contract ), Generation Program web site, Novartis (Novartis Pharmaceuticals), and Helpful Links Provided by to the page, providing funding attribution, program context, and external resources for the study.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page. This reflects a new page revision in the site's content management system.SummaryDifference0.0%

- Check58 days agoChange DetectedPlatform release updated from v3.6.3 to v3.6.4, reflecting a maintenance update to the site. No study details or page text were changed.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.0, indicating a deployment update to the site. The update does not alter the study details or user-facing content on the page.SummaryDifference0.0%

Stay in the know with updates to CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.